Phase III/Seroquel SR Bipolar Depression Monotherapy - US

Mise à jour : Il y a 5 ans
Référence : NCT00422214

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The purpose of this study is to determine the safety and efficacy of sustained-release quetiapine fumarate (Seroquel®) in the treatment of patients with Acute Bipolar Depression for 8 weeks. PLEASE NOTE: Seroquel SR and Seroquel XR refer to the same formulation. The SR designation was changed to XR after consultation with FDA.


Critère d'inclusion

  • Affective Psychosis, Bipolar,Depression, Bipolar,manic-depressive psychosis,Psychoses, Manic-Depressive

Liens